Carregant...
Nose-to-Brain Delivery
Nose-to-brain delivery represents a big challenge. In fact there is a large number of neurological diseases that require therapies in which the drug must reach the brain, avoiding the difficulties due to the blood–brain barrier (BBB) and the problems connected with systemic administration, such as d...
Guardat en:
| Publicat a: | Pharmaceutics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7076467/ https://ncbi.nlm.nih.gov/pubmed/32041344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12020138 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|